1. Market Research
  2. > Pathology Industry

Ovarian Cancer Industry, February 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, Antigen, Cancer Drug, Pharmaceutical, Therapeutics, Biomarker, Cancer Diagnostic, Molecular Diagnostic, Surgery.


 
1-10 of 34 reports for Ovarian Cancer

Purchase Reports From Reputable Market Research Publishers

 Metastatic Ovarian Cancer-Pipeline Insights, 2016

Metastatic Ovarian Cancer-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Metastatic Ovarian Cancer-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Metastatic Ovarian ...

Global Ovarian Cancer Partnering 2010 to 2016

Global Ovarian Cancer Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • February 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

 Epithelial Ovarian Cancer-Pipeline Insights, 2016

Epithelial Ovarian Cancer-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Epithelial Ovarian Cancer-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Epithelial Ovarian ...

Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Ovarian Cancer - Pipeline Review, H2 2015

Ovarian Cancer - Pipeline Review, H2 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Markets Direct

Ovarian Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H2 2015’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report ...

Frontier Pharma: Ovarian Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Ovarian Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • December 2015
  • by GBI Research

Frontier Pharma: Ovarian Cancer - Identifying and Commercializing First-in-Class Innovation Summary Ovarian cancer is the sixth most common cancer in females and it also has the highest mortality rate ...

Epithelial Ovarian Cancer - Pipeline Review, H2 2015

Epithelial Ovarian Cancer - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • October 2015
  • by Global Markets Direct

Epithelial Ovarian Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H2 2015’, provides an overview of the Epithelial Ovarian Cancer’s ...

Metastatic Ovarian Cancer - Pipeline Review, H2 2015

Metastatic Ovarian Cancer - Pipeline Review, H2 2015

  • $ 2 000
  • Company report
  • October 2015
  • by Global Markets Direct

Metastatic Ovarian Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Metastatic Ovarian Cancer - Pipeline Review, H2 2015’, provides an overview of the Metastatic Ovarian Cancer’s ...

Ovarian Cancer Treatment Drugs Companies in China

Ovarian Cancer Treatment Drugs Companies in China

  • $ 1 800
  • Industry report
  • October 2015
  • by Asia Market Information & Development Company

This study focuses on China’s Ovarian Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions ...

About 1 800 reports for Ovarian Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description

  • December 2013
    15 pages
  • Cancer  

    Ovarian Cancer  

View report >

Hormone Industry

June 2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.